News Bio-Rad Laboratories, Inc. NYSE

Stocks

BIO.B

US0905721082

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 16:10:00 2026-08-20 EDT			5-day change	1st Jan Change
365.08 ^USD	+8.33%		+8.33%	+17.50%

08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
08-05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

All News

Mentions Relevance

08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
08-05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT
08-04	Bio Rad Laboratories : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
08-04	Bio-Rad Laboratories, Inc., Q2 2026 Earnings Call, Aug 04, 2026
08-04	Bio-Rad: Q2 Earnings Snapshot	AQ
08-04	Bio-Rad Laboratories Q2 Adjusted Earnings Rise, Revenue Falls	MT
08-04	Bio-Rad Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of 2026	CI
08-04	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.0M, vs. FactSet Est of $624.0M	MT
08-04	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q2 Adjusted EPS $2.62 per Share, vs. FactSet Est of $1.75	MT
08-04	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
08-04	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-04	Bio-Rad Reports Second-Quarter 2026 Financial Results	BU
07-23	Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026	BU
06-03	Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM
05-19	Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 08:30 AM
05-18	Bio-Rad Laboratories Draws Elliott Investment as Activist Investor Pushes for Turnaround	MT
05-18	Elliott Investment Management LP Urges Improvement In Share Price And Value Creation for Shareholders	CI
05-17	Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports	RE
05-17	Activist investor Elliott builds stake in life-science tools supplier Bio-Rad Laboratories, WSJ reports	RE
05-17	Activist Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories - WSJ	RE
05-15	Bio-Rad Laboratories' Sales Growth Set to Recover in 2027, RBC Says	MT
05-11	Bio-Rad to Participate in Upcoming Investor Conferences	AQ
05-08	Bio-Rad to Participate in Upcoming Investor Conferences	BU
05-01	Bio-Rad Laboratories, Inc., Q1 2026 Earnings Call, Apr 30, 2026
04-30	Bio Rad Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU